Drug Co. CEO Martin Shkreli Arrested On Securities Fraud Charges
Shkreli, who recently has faced criticism for hiking prices for life-saving medicines made by his company, faces allegations that he illegally took stock from a biotechnology firm he started in order to pay off unrelated debts. News stories also cover developments related to big pharma's efforts to obtain customers' medical data in exchange for drug discounts, and studies related to savings that could result from Medicaid drug rebates as well as funding for clinical trials.